title: [Facilitated revascularisation in myocardial infarction with ST-segment elevation].
abstract: OBJECTIVE
  The authors performed urgent coronarography and revascularisation after administering a combined half dose of alteplase (tissue plazminogen activator) and eptifibatide (glycoprotein II/bIIIa receptor blocking agent) to patients suffering from acute coronary syndromes with persistent ST-segment elevation.
  
  
  METHODS
  During the period between 01 April to 15 December, 2001. 20 patients (16 men and 4 women, mean age: 55.6 years) were treated. The localization of infarction on the basis of ST-segment elevation was: 9 cases inferior, 10 cases anterior and patient with left bundle branch block in 1 cases. The mean time between the infarct related angina and hospital admission was 158 (30-600) minutes. The combined medical therapy was initiated after 34 (15-150) minutes on the average admission, and 123 (71-210) minutes later the patients were in the catheter laboratory.
  
  
  RESULTS
  Coronarography showed TIMI-0 flow in 4 cases, TIMI-2 flow in 3 cases and TIMI-3 flow in 13 cases. Acute percutan coronary intervention was done in 14 cases, aorto-coronary bypass surgery was performed in 4 cases (2 of them were emergency operations, the other 2 were done electively). Besides postpunctional haematomas, hemorrhagic complications in the form of haematemesis were observed in 2 cases, but there was no need for transfusion. The mean CK-MB release (between 14 patients) was 230.4 (30-1176) U/l. One patient died after the emergency bypass surgery.
  
  
  CONCLUSIONS
  On the basis of initial results the authors emphasize the importance of working out the optimal revascularisation strategy for acute coronary syndrome patients with ST-segment elevation in every Hungarian catheter centre. The authors find this method--in their case the catheter laboratory is 60 kms away, time of transport is approximately 70-90 minutes--an effective and safe alternative therapy in patients under the age of 75 years with acute myocardial infarction.
authors.affiliation: Tolna Megyei Onkormányzat Balassa János Kórháza, Szekszárd, Kardiológiai Osztály.
authors.forename: Mihály
authors.initials: M
authors.lastname: Józan-Jilling
authors.forename: Iván
authors.initials: I
authors.lastname: Horváth
authors.forename: Ernó
authors.initials: E
authors.lastname: Kis
authors.forename: Imre
authors.initials: I
authors.lastname: Bodnár
authors.forename: Magdolna
authors.initials: M
authors.lastname: Baross
authors.forename: Arpád
authors.initials: A
authors.lastname: Zsigmond
authors.forename: Eva
authors.initials: E
authors.lastname: Kovács
authors.forename: Lajos
authors.initials: L
authors.lastname: Papp
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D017023:Coronary Angiography; D000077542:Eptifibatide; D005260:Female; D006329:Heart Conduction System / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D010455:Peptides / Q000008:administration & dosage*; D010960:Plasminogen Activators / Q000008:administration & dosage; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000008:administration & dosage; D012189:Retrospective Studies; D015912:Thrombolytic Therapy / Q000379:methods; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D000077542:Eptifibatide
vernacular_title: Facilitált revascularisatiós stratégia ST-elevációs myocardiuminfarctusban.